Analytical platform for rapid profiling of postbiotics in fermented plant-based foods using CE, GC-MS, and LC-MS. Measures short-chain fatty acids, amino acids, vitamins, and bile acids to evaluate how microbial fermentation alters phytochemistry and gut-health-related metabolites.
This research program develops rapid, multi-platform analytical methods to measure postbiotics in fermented plant-based foods such as oats, rice, beans, and potatoes. Postbiotics, including short-chain fatty acids (SCFAs), amino acids, vitamins, and bile acids, are bioactive compounds produced or modified through microbial fermentation and are increasingly linked to gut health and nutritional quality. The work investigates how interactions between plant genotypes and fermentation microorganisms change postbiotic profiles, offering food producers, nutrition researchers, and supplement developers a faster path to characterizing functional ingredients.
Analytical platforms and methods:
Key features:
The CE-based SCFA detection method has been validated in prior animal-model studies, and GC-MS metabolite profiling of fermented rice bran has been demonstrated in published work. The program is currently at the validation stage, with planned experiments to benchmark CE-IPD against GC-MS derivatization methods and to expand LC-MS profiling of additional postbiotic classes. The approach is positioned for further development and partnership-driven scaling toward routine quality and research applications in functional food and nutrition science.
Georgia State University is a comprehensive public research university in downtown Atlanta, serving a large and diverse student body with a rapidly growing research enterprise. An urban innovation district and co-located collaboration spaces link faculty and students with corporate partners for prototyping, user testing, and joint problem-solving. Shared core laboratories and campus computing resources support industry-sponsored work, while proximity to Fortune 500 headquarters, major hospital systems, and the CDC enables quick access to real-world testbeds. Research is backed by competitive federal funding from agencies such as NIH, NSF, and DoD. A dedicated technology transfer office streamlines IP, licensing, and startup formation to speed commercialization.